Abbott Laboratories (ABT): Today's Featured Health Services Winner

Abbott Laboratories ( ABT) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.5%. By the end of trading, Abbott Laboratories rose $0.49 (1.4%) to $35.41 on average volume. Throughout the day, 7,403,998 shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 7,063,300 shares. The stock ranged in a price between $34.94-$35.47 after having opened the day at $34.95 as compared to the previous trading day's close of $34.92. Other companies within the Health Services industry that increased today were: Response Genetics ( RGDX), up 8.0%, Addus Homecare Corporation ( ADUS), up 5.5%, Harvard Bioscience ( HBIO), up 4.8% and ImmunoCellular Therapeutics ( IMUC), up 4.8%.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Abbott Laboratories has a market cap of $53.4 billion and is part of the health care sector. Shares are up 6.6% year to date as of the close of trading on Friday. Currently there are 12 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Abbott Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share.

On the negative front, Natus Medical ( BABY), down 13.2%, Pingtan Marine Enterprise ( PME), down 12.8%, Alpha Pro Tech ( APT), down 6.9% and Daxor Corporation ( DXR), down 3.8%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Roku, Amazon, Teladoc, Weyerhaeuser: 'Mad Money' Lightning Round

Roku, Amazon, Teladoc, Weyerhaeuser: 'Mad Money' Lightning Round

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

The 5 Best Dividend Aristocrats For 2018

The 5 Best Dividend Aristocrats For 2018

Lam Research: Cramer's Top Takeaways

Lam Research: Cramer's Top Takeaways